Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	1075236-89-3
Formula :	C₂₄H₂₈N₆O₃
M.W :	448.52
SMILES Code :	O=C(C=NC(C=C1)=C23)N3[C@H](CN4CCC(NCC5=CC(CCCO6)=C6C=N5)CC4)CN2C1=O
Synonyms :	GSK2140944
MDL No. :	MFCD27987926

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319
Precautionary Statements:	P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Nontuberculous mycobacteria (NTM) isolates	0.25 to >64 µg/mL		To evaluate the in vitro activity of gepotidacin against NTM, showing variable MICs with the lowest MICs observed for M. fortuitum complex, M. mucogenicum complex, M. kansasii, and M. marinum.	Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0168423
Escherichia coli EC-IR5-3257	4 mg/liter	24 hours	To evaluate bactericidal activity of gepotidacin against multiple E. coli strains, median free-drug AUC/MIC ratios were determined	Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0012221
Escherichia coli EC-25922	1 mg/liter	24 hours	To evaluate bactericidal activity of gepotidacin against multiple E. coli strains, median free-drug AUC/MIC ratios were determined	Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0012221
Escherichia coli EC-ALL	4 mg/liter	24 hours	To evaluate bactericidal activity of gepotidacin against multiple E. coli strains, median free-drug AUC/MIC ratios were determined	Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0012221
Escherichia coli NCTC 13441	2 mg/liter	24 hours	To identify the PK-PD index associated with gepotidacin efficacy against E. coli, free-drug AUC/MIC ratio was found to be most correlated with bacterial burden change	Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0012221
Vero cells	0.016-0.5 mg/L	3 weeks	Evaluate the in vitro activity of gepotidacin against 54 Mycoplasma genitalium isolates, showing efficacy against all strains with MIC90 of 0.25 mg/L, independent of resistance profiles.	Emerg Microbes Infect. 2020 Dec;9(1):1388-1392
Mycobacterium tuberculosis gyrase	25 μM	1 hour	To evaluate the inhibitory effect of Gepotidacin on Mycobacterium tuberculosis DNA gyrase. Results showed that Gepotidacin competitively binds to DNA gyrase with BDM71403, forming a stable ternary complex and inhibiting enzyme activity.	iScience. 2024 Sep 16;27(10):110967
Escherichia coli (including ESBL producers)	2-4 μg/ml	24 hours	Evaluate the MIC and MBC of Gepotidacin against E. coli, showing bactericidal activity with MBC/MIC ratios ≤2.	Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00468-17
Streptococcus pneumoniae (including penicillin-nonsusceptible)	0.25-0.5 μg/ml	24 hours	Evaluate the MIC and MBC of Gepotidacin against S. pneumoniae, showing bactericidal activity with MBC/MIC ratios ≤2.	Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00468-17
Staphylococcus aureus (including MRSA and MSSA)	0.25-0.5 μg/ml	24 hours	Evaluate the MIC and MBC of Gepotidacin against S. aureus, showing bactericidal activity with MBC/MIC ratios ≤2.	Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00468-17
Stenotrophomonas maltophilia clinical isolates	0.25–16 mg/L	24 hours	To evaluate the antibacterial activity of gepotidacin against clinical S. maltophilia isolates, showing MIC range of 0.25–16 mg/L with time- and strain-dependent killing effect.	Antibiotics (Basel). 2022 Feb 1;11(2):192
Escherichia coli TOP10-3 (GyrAP35L, ParCD79N)	16 μg/mL		To evaluate the MIC of gepotidacin against E. coli strain carrying both GyrAP35L and ParCD79N mutations.	ACS Infect Dis. 2024 Apr 12;10(4):1137-1151
Escherichia coli TOP10-2 (GyrAWT, ParCD79N)	0.125 μg/mL		To evaluate the MIC of gepotidacin against E. coli strain carrying the ParCD79N mutation.	ACS Infect Dis. 2024 Apr 12;10(4):1137-1151
Escherichia coli TOP10-1 (GyrAP35L, ParCWT)	0.125 μg/mL		To evaluate the MIC of gepotidacin against E. coli strain carrying the GyrAP35L mutation.	ACS Infect Dis. 2024 Apr 12;10(4):1137-1151
Escherichia coli TOP10	0.125 μg/mL		To evaluate the minimum inhibitory concentration (MIC) of gepotidacin against E. coli TOP10 strain.	ACS Infect Dis. 2024 Apr 12;10(4):1137-1151
Francisella tularensis strains	0.5 to 1 mg/mL		Evaluate the in vitro activity of Gepotidacin against various F. tularensis strains	Antimicrob Agents Chemother. 2023 May 17;67(5):e0138122

BALB/c mice	Murine neutropenic M. fortuitum infection model	Oral	10 mg/kg	Once daily for 15 days	To evaluate the in vivo activity of Gepotidacin in a murine neutropenic M. fortuitum infection model. Results showed that GEPO at 10 mg/kg significantly reduced bacterial load in various organs, outperforming amikacin.	Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0056422
Galleria mellonella (greater wax moth)	Infection model	Injection	600 mg/L (equivalent to 20 mg/kg body weight)	Single dose, monitored for 5 days	To determine the in vivo activity of gepotidacin against S. maltophilia infection, showing treated larvae survival rate increased from 61% to 90% after 2 days.	Antibiotics (Basel). 2022 Feb 1;11(2):192
Cynomolgus macaques	Inhalational tularemia model	Intravenous infusion	72 mg/kg/day	Every 8 hours for 10 days	Evaluate the efficacy of Gepotidacin in the cynomolgus macaque model of inhalational tularemia, results showed 100% survival in the Gepotidacin-treated group compared to 12.5% in the saline control group	Antimicrob Agents Chemother. 2023 May 17;67(5):e0138122
Long Evans rats	Juvenile rat model	Oral gavage	300/1,250 mg/kg/day	Once daily from postnatal day (PND) 4 to PND 32	To assess the tolerability and toxicity of gepotidacin in juvenile rats, particularly its effects on joints. Results showed no skeletal effects on articular surfaces of the femoral head or sti?e joint at the highest tolerated dose.	Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0048322

{[proInfo.proName]}

CAS No.: 1075236-89-3

{[proInfo.proName]}

CAS No.: 1075236-89-3

Alternative Products

Product Details of Gepotidacin

Safety of Gepotidacin

Related Pathways of Gepotidacin

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT05271799	Healthy Volunteers	PHASE1	COMPLETED	2022-04-22	GSK Investigational Site, Las ... More >>Vegas, Nevada, 89113, United States Less <<
NCT02294682	Gonorrhea	PHASE2	COMPLETED	2016-07-27	GSK Investigational Site, Foun... More >>tain Valley, California, 92708, United States\|GSK Investigational Site, Los Angeles, California, 90028, United States\|GSK Investigational Site, Los Angeles, California, 90069, United States\|GSK Investigational Site, Palm Springs, California, 92262, United States\|GSK Investigational Site, San Francisco, California, 94103, United States\|GSK Investigational Site, Orlando, Florida, 32806, United States\|GSK Investigational Site, Atlanta, Georgia, 30308, United States\|GSK Investigational Site, Indianapolis, Indiana, 46202, United States\|GSK Investigational Site, New Orleans, Louisiana, 70119, United States\|GSK Investigational Site, Omaha, Nebraska, 68114, United States\|GSK Investigational Site, Cleveland, Ohio, 44109, United States\|GSK Investigational Site, Jenkintown, Pennsylvania, 19046, United States\|GSK Investigational Site, San Juan, 00927, Puerto Rico\|GSK Investigational Site, London, SW10 9NH, United Kingdom Less <<
NCT03562117	Infections, Bacterial	PHASE1	COMPLETED	2018-12-26	GSK Investigational Site, Miam... More >>i, Florida, 33136, United States\|GSK Investigational Site, Orlando, Florida, 32809, United States Less <<
NCT03568942	Infections, Bacterial	PHASE2	COMPLETED	2019-01-07	GSK Investigational Site, La M... More >>esa, California, 91942, United States Less <<
NCT06597344	Urinary Tract Infections	PHASE3	RECRUITING	2025-03-19	GSK Investigational Site, Birm... More >>ingham, Alabama, 35205-1628, United States\|GSK Investigational Site, Modesto, California, 95350-5365, United States\|GSK Investigational Site, North Hollywood, California, 91606-3287, United States\|GSK Investigational Site, Pasadena, California, 91101-2453, United States\|GSK Investigational Site, San Diego, California, 92120-5259, United States\|GSK Investigational Site, Valencia, California, 91355, United States\|GSK Investigational Site, Hialeah, Florida, 33016, United States\|GSK Investigational Site, Miami, Florida, 33135, United States\|GSK Investigational Site, Ormond Beach, Florida, 32174-6302, United States\|GSK Investigational Site, Palm Springs, Florida, 33406-7671, United States\|GSK Investigational Site, Palm Springs, Florida, 33461, United States\|GSK Investigational Site, Plant City, Florida, 33563-4202, United States\|GSK Investigational Site, Sweetwater, Florida, 33172-2741, United States\|GSK Investigational Site, West Palm Beach, Florida, 33409-3401, United States\|GSK Investigational Site, Smyrna, Georgia, 30082-5192, United States\|GSK Investigational Site, East Brunswick, New Jersey, 08816-1407, United States\|GSK Investigational Site, New York, New York, 10016-7313, United States\|GSK Investigational Site, Columbus, Ohio, 43228, United States\|GSK Investigational Site, Scottdale, Pennsylvania, 15683, United States\|GSK Investigational Site, Forney, Texas, 75126-4174, United States\|GSK Investigational Site, Houston, Texas, 77036, United States\|GSK Investigational Site, Houston, Texas, 77054, United States\|GSK Investigational Site, Houston, Texas, 77087, United States\|GSK Investigational Site, Kingwood, Texas, 26537, United States\|GSK Investigational Site, Mesquite, Texas, 75149, United States\|GSK Investigational Site, Missouri City, Texas, 77459-4756, United States\|GSK Investigational Site, Bountiful, Utah, 84010-4943, United States Less <<
NCT02729038	Infections, Bacterial	PHASE1	COMPLETED	2017-06-20	GSK Investigational Site, Miam... More >>i, Florida, 33136, United States\|GSK Investigational Site, Orlando, Florida, 32809, United States\|GSK Investigational Site, Minneapolis, Minnesota, 55404, United States Less <<
NCT04484740	Gonorrhea\|Infection, Bacterial	PHASE1	COMPLETED	2023-05-27	MUVienna, Vienne, 1090, Austri... More >>a\|CHU POITIERS Département ORL, Poitiers, 86021, France\|CHU POITIERS Département Urologie, Poitiers, 86021, France\|CHRU TOURS Département Urologie, Tours, 37000, France Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.23mL 0.45mL 0.22mL	11.15mL 2.23mL 1.11mL	22.30mL 4.46mL 2.23mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed